414 related articles for article (PubMed ID: 28802125)
1. Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies.
Eldehna WM; Abo-Ashour MF; Nocentini A; Gratteri P; Eissa IH; Fares M; Ismael OE; Ghabbour HA; Elaasser MM; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2017 Oct; 139():250-262. PubMed ID: 28802125
[TBL] [Abstract][Full Text] [Related]
2. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
Awadallah FM; El-Waei TA; Hanna MM; Abbas SE; Ceruso M; Oz BE; Guler OO; Supuran CT
Eur J Med Chem; 2015; 96():425-35. PubMed ID: 25912674
[TBL] [Abstract][Full Text] [Related]
4. Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX.
Allam HA; Fahim SH; F Abo-Ashour M; Nocentini A; Elbakry ME; Abdelrahman MA; Eldehna WM; Ibrahim HS; Supuran CT
Eur J Med Chem; 2019 Oct; 179():547-556. PubMed ID: 31276899
[TBL] [Abstract][Full Text] [Related]
5. 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights.
Abo-Ashour MF; Eldehna WM; Nocentini A; Bonardi A; Bua S; Ibrahim HS; Elaasser MM; Kryštof V; Jorda R; Gratteri P; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2019 Dec; 184():111768. PubMed ID: 31629164
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer.
Eldehna WM; Nocentini A; Al-Rashood ST; Hassan GS; Alkahtani HM; Almehizia AA; Reda AM; Abdel-Aziz HA; Supuran CT
Bioorg Chem; 2018 Dec; 81():425-432. PubMed ID: 30219719
[TBL] [Abstract][Full Text] [Related]
7. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines.
Abdel Gawad NM; Amin NH; Elsaadi MT; Mohamed FMM; Angeli A; De Luca V; Capasso C; Supuran CT
Bioorg Med Chem; 2016 Jul; 24(13):3043-3051. PubMed ID: 27234893
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Szafrański K; Vullo D; Supuran CT
Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
[TBL] [Abstract][Full Text] [Related]
10. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, molecular modelling and QSAR study of new
Said MF; George RF; Petreni A; Supuran CT; Mohamed NM
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):701-717. PubMed ID: 35168458
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity.
Eldehna WM; Abdelrahman MA; Nocentini A; Bua S; Al-Rashood ST; Hassan GS; Bonardi A; Almehizia AA; Alkahtani HM; Alharbi A; Gratteri P; Supuran CT
Bioorg Chem; 2019 Sep; 90():103102. PubMed ID: 31299596
[TBL] [Abstract][Full Text] [Related]
13. Novel hydrazido benzenesulfonamides-isatin conjugates: Synthesis, carbonic anhydrase inhibitory activity and molecular modeling studies.
Abo-Ashour MF; Eldehna WM; Nocentini A; Ibrahim HS; Bua S; Abou-Seri SM; Supuran CT
Eur J Med Chem; 2018 Sep; 157():28-36. PubMed ID: 30071407
[TBL] [Abstract][Full Text] [Related]
14. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity.
Soliman AM; Ghorab MM; Bua S; Supuran CT
Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
Ghorab MM; Alsaid MS; Ceruso M; Nissan YM; Supuran CT
Bioorg Med Chem; 2014 Jul; 22(14):3684-95. PubMed ID: 24878360
[TBL] [Abstract][Full Text] [Related]
16. Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII.
Eldehna WM; Fares M; Ceruso M; Ghabbour HA; Abou-Seri SM; Abdel-Aziz HA; Abou El Ella DA; Supuran CT
Eur J Med Chem; 2016 Mar; 110():259-66. PubMed ID: 26840366
[TBL] [Abstract][Full Text] [Related]
17. Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors.
Elimam DM; Eldehna WM; Salem R; Bonardi A; Nocentini A; Al-Rashood ST; Elaasser MM; Gratteri P; Supuran CT; Allam HA
Eur J Med Chem; 2022 Jan; 228():114008. PubMed ID: 34871842
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.
Suthar SK; Bansal S; Lohan S; Modak V; Chaudhary A; Tiwari A
Eur J Med Chem; 2013 Aug; 66():372-9. PubMed ID: 23827177
[TBL] [Abstract][Full Text] [Related]
19. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes.
Gul HI; Yamali C; Bulbuller M; Kirmizibayrak PB; Gul M; Angeli A; Bua S; Supuran CT
Bioorg Chem; 2018 Aug; 78():290-297. PubMed ID: 29621641
[TBL] [Abstract][Full Text] [Related]
20. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and
Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]